Sign In
5 Jan 2010 07:00
ο»Ώ
CyprotexΒ PLC
("Cyprotex" or "the Company" or "the Group")
Trading Update
Cyprotex (LSE:CRX), the drug discovery technology and information company,Β notesΒ yesterday's fall in the share price and is unaware of any reason for this share price movement. The Company re-iteratesΒ that its current trading is inΒ line with market expectationsΒ following its trading update ofΒ 20 November 2009.Β
The Company expects to release aΒ trading update towards the end of January 2010, in respect of calendar year ended 31 December 2009.
For further information:
|
CyprotexΒ PLCΒ |
Tel: +44 (0) 1625 505 100 |
|
|
Dr Anthony Baxter, Chief Executive Officer John Dootson, Chief Financial Officer |
||
|
ir@cyprotex.com |
www.cyprotex.comΒ |
|
|
Noble & Company |
Tel: +44 (0) 20 7763 2200 |
|
|
John Llewellyn-Lloyd john.llewellyn-lloyd@noblegp.com |
www.noblegp.com |
|
|
Financial Dynamics |
Tel: +44 (0) 20 7831 3113 |
|
|
Ben BrewertonΒ /Β Ben AtwellΒ /Β John Dineen |
||
|
cyprotex@fd.com |
www.fd.com |
|
Follow the stocks
